GSK shares dive as weaker sales and mounting costs unnerve investors
13h agonow
What the 2 sources said
“GSK shares dive as weaker sales and mounting costs unnerve investors”
British pharma company reports declining profits amid weaker vaccine sales and looming patent loss for blockbuster HIV drug Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better-than-expected financial results, as investors were unnerved by weaker vaccine sales, restructuring charges and its overall outlook. Britain’s second-biggest pharmaceutical company reported a 19% decline in pre-tax profit to £1.9bn in the July to September quarter and…
Read at The Guardian – World“GSK shares dive as weaker vaccine sales and restructuring charges unnerve investors”
British pharma company reports declining profits amid concerns over looming patent loss for blockbuster HIV drug Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better than expected financial results, as investors were unnerved by weaker vaccine sales, restructuring charges and its overall outlook. Britain’s second-biggest pharmaceutical company reported a 19% decline in pre-tax profit to £1.9bn in the July to September quarter and £318m of…
Read at The Guardian – UKWhat the reports add
Written by AI from the outlets' own summaries, when someone asks. Each line names the outlets that reported it, and the words under it are theirs.